Literature DB >> 30039189

Percutaneous coronary intervention: balloons, stents and scaffolds.

Roisin Colleran1, Adnan Kastrati2,3.   

Abstract

In this review, major achievements in the field of percutaneous coronary interventions are delineated with particular focus on Germany's contribution. The review deals with important developments, including the first heart catheterization and coronary angiography, first coronary balloon angioplasty and refinement of the technique, coronary stenting and optimization of adjunctive antithrombotic treatment, drug-eluting stents and balloons, as well as bioresorbable polymeric and metallic drug-eluting scaffolds.

Entities:  

Keywords:  Balloon angioplasty; Coronary artery disease; Drug-coated balloon; Drug-eluting scaffold; Drug-eluting stent; Percutaneous coronary intervention; Restenosis; Stent; Thrombosis

Mesh:

Year:  2018        PMID: 30039189     DOI: 10.1007/s00392-018-1328-x

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  67 in total

1.  Influence of topography on endothelialization of stents: clues for new designs.

Authors:  C Simon; J C Palmaz; E A Sprague
Journal:  J Long Term Eff Med Implants       Date:  2000

Review 2.  Pathological aspects of bioresorbable stent implantation.

Authors:  Oscar D Sanchez; Kazuyuki Yahagi; Robert A Byrne; Hiroyoshi Mori; Roya Zarpak; Eric Wittchow; Nicolas Foin; Renu Virmani; Michael Joner
Journal:  EuroIntervention       Date:  2015       Impact factor: 6.534

3.  Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial.

Authors:  Michael Haude; Hüseyin Ince; Alexandre Abizaid; Ralph Toelg; Pedro Alves Lemos; Clemens von Birgelen; Evald Høj Christiansen; William Wijns; Franz-Josef Neumann; Christoph Kaiser; Eric Eeckhout; Soo Teik Lim; Javier Escaned; Hector M Garcia-Garcia; Ron Waksman
Journal:  Lancet       Date:  2015-10-12       Impact factor: 79.321

4.  Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial.

Authors:  A Kastrati; J Mehilli; J Dirschinger; F Dotzer; H Schühlen; F J Neumann; M Fleckenstein; C Pfafferott; M Seyfarth; A Schömig
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

Review 5.  Coronary balloon angioplasty, stents, and scaffolds.

Authors:  Robert A Byrne; Gregg W Stone; John Ormiston; Adnan Kastrati
Journal:  Lancet       Date:  2017-08-19       Impact factor: 79.321

Review 6.  Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials.

Authors:  Salvatore Cassese; Robert A Byrne; Gjin Ndrepepa; Sebastian Kufner; Jens Wiebe; Janika Repp; Heribert Schunkert; Massimiliano Fusaro; Takeshi Kimura; Adnan Kastrati
Journal:  Lancet       Date:  2015-11-17       Impact factor: 79.321

7.  Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial.

Authors:  Michael Haude; Raimund Erbel; Paul Erne; Stefan Verheye; Hubertus Degen; Dirk Böse; Paul Vermeersch; Inge Wijnbergen; Neil Weissman; Francesco Prati; Ron Waksman; Jacques Koolen
Journal:  Lancet       Date:  2013-03-09       Impact factor: 79.321

8.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty.

Authors:  U Sigwart; J Puel; V Mirkovitch; F Joffre; L Kappenberger
Journal:  N Engl J Med       Date:  1987-03-19       Impact factor: 91.245

9.  Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis.

Authors:  Bruno Scheller; Ulrich Speck; Claudia Abramjuk; Ulrich Bernhardt; Michael Böhm; Georg Nickenig
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

10.  Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.

Authors:  Julinda Mehilli; Robert A Byrne; Anna Wieczorek; Raisuke Iijima; Stefanie Schulz; Olga Bruskina; Jürgen Pache; Rainer Wessely; Albert Schömig; Adnan Kastrati
Journal:  Eur Heart J       Date:  2008-06-11       Impact factor: 29.983

View more
  4 in total

1.  Polymer-free drug-coated vs. bare-metal coronary stents in patients undergoing non-cardiac surgery: a subgroup analysis of the LEADERS FREE trial.

Authors:  Gert Richardt; Mohammad Abdelghani; Abdelhakim Allali; Ralph Toelg; Mohamed Abdellaoui; Florian Krackhardt; Rune Wiseth; Marie-Claude Morice; Samuel Copt; Hans-Peter Stoll; Philip Urban
Journal:  Clin Res Cardiol       Date:  2020-05-21       Impact factor: 5.460

2.  Qualitative and quantitative neointimal characterization by optical coherence tomography in patients presenting with in-stent restenosis.

Authors:  Erion Xhepa; Robert A Byrne; Fernando Rivero; Andi Rroku; Javier Cuesta; Gjin Ndrepepa; Sebastian Kufner; Teresa Bastante Valiente; Salvatore Cassese; Marcos Garcia-Guimaraes; Anna Lena Lahmann; Himanshu Rai; Heribert Schunkert; Michael Joner; María José Pérez-Vizcayno; Nieves Gonzalo; Fernando Alfonso; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2019-02-19       Impact factor: 5.460

3.  A Multilayer Functionalized Drug-Eluting Balloon for Treatment of Coronary Artery Disease.

Authors:  Hak-Il Lee; Won-Kyu Rhim; Eun-Young Kang; Bogyu Choi; Jun-Hyeok Kim; Dong-Keun Han
Journal:  Pharmaceutics       Date:  2021-04-23       Impact factor: 6.321

4.  Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study.

Authors:  Vassilios S Vassiliou; Simon C Eccleshall; Ioannis Merinopoulos; Tharusha Gunawardena; Upul Wickramarachchi; Paul Richardson; Clint Maart; Sulfi Sreekumar; Chris Sawh; Trevor Wistow; Toomas Sarev; Alisdair Ryding; Tim Gilbert; Aris Perperoglou
Journal:  Clin Res Cardiol       Date:  2020-09-02       Impact factor: 5.460

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.